Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.28 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.52.
Market Cap
9.28T
Revenue
4.66T
Profits
187.36B
PE Ratio
49.52
Profit Margin
4.02%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | -1.37% | 2,112,688 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 626.09B | -0.77% | 5,945,942 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 441.94B | 0.85% | 4,491,436 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 361.00B | -1.60% | 3,400,214 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 321.77B | -0.38% | 6,343,838 | 66.57B |
| 6 | NVS | Novartis AG | 294.87B | -1.39% | 1,073,156 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 248.17B | -1.95% | 2,754,505 | 61.37B |
| 8 | AMGN | Amgen Inc. | 223.98B | -0.70% | 2,030,337 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 223.70B | 0.89% | 1,656,288 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.73B | -1.17% | 7,834,672 | 50.34B |
| 11 | ABT | Abbott Laboratories | 189.86B | 1.01% | 6,744,772 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 168.35B | 2.04% | 5,493,556 | 30.46B |
| 13 | PFE | Pfizer Inc. | 151.73B | -1.59% | 37,942,528 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.83B | -0.92% | 2,473,835 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.75B | 2.00% | 4,124,042 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.25B | 1.10% | 1,064,463 | 12.59B |
| 17 | SYK | Stryker Corporation | 133.54B | 0.68% | 1,627,368 | 25.84B |
| 18 | BMY | Bristol-Myers Squibb Company | 129.94B | -1.90% | 9,367,483 | 49.19B |
| 19 | CVS | CVS Health Corporation | 119.58B | -2.27% | 8,122,806 | 412.65B |
| 20 | MDT | Medtronic plc | 116.07B | 1.42% | 8,392,531 | 36.36B |
| 21 | MCK | McKesson Corporation | 105.14B | 2.49% | 805,177 | 410.98B |
| 22 | SNY | Sanofi | 104.24B | 0.18% | 2,839,701 | 55.89B |
| 23 | GSK | GSK plc | 102.63B | -2.42% | 2,924,606 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.08B | -0.63% | 1,122,070 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.66B | -1.84% | 907,272 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.58B | -1.37% | 940,037 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.19B | 1.45% | 13,454,213 | 21.00B |
| 28 | CI | The Cigna Group | 72.37B | -1.63% | 1,740,607 | 282.38B |
| 29 | COR | Cencora, Inc. | 63.71B | 2.73% | 1,368,665 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.09B | -0.40% | 2,339,215 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 55.88B | 1.30% | 3,007,877 | 254.25B |
| 32 | ARGX | argenx SE | 54.05B | -0.16% | 476,347 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 53.99B | 1.77% | 3,138,661 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.41B | 0.99% | 1,515,552 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.22B | -1.53% | 425,660 | 4.55B |
| 36 | MDLN | Medline Inc. | 46.07B | 3.64% | 9,095,147 | 29.94B |
| 37 | NTRA | Natera, Inc. | 45.08B | -1.77% | 953,144 | 2.71B |
| 38 | HUM | Humana Inc. | 44.77B | -3.34% | 733,244 | 145.68B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.06B | -0.69% | 1,680,668 | - |
| 40 | HLN | Haleon plc | 43.48B | - | 8,790,672 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 42.51B | 0.94% | 8,040,856 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 42.22B | 0.52% | 1,199,336 | 7.23B |
| 43 | ONC | BeOne Medicines AG | 40.85B | 0.08% | 634,912 | 6.13B |
| 44 | WAT | Waters Corporation | 40.75B | 0.78% | 669,766 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 40.14B | 0.76% | 1,084,501 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.43B | 0.81% | 1,645,713 | 3.32B |
| 47 | ALC | Alcon Inc. | 36.38B | 2.34% | 3,967,677 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 33.79B | 2.14% | 5,971,347 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.23B | -0.31% | 2,394,336 | 2.54B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.86B | -0.26% | 2,227,589 | 21.27B |
| 51 | RMD | ResMed Inc. | 32.43B | 2.18% | 1,239,266 | 5.65B |
| 52 | CNC | Centene Corporation | 32.05B | -2.54% | 2,441,528 | 180.30B |
| 53 | ZTS | Zoetis Inc. | 31.14B | 0.69% | 4,132,027 | 9.53B |
| 54 | BIIB | Biogen Inc. | 30.13B | -1.56% | 936,828 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.60B | 1.94% | 1,440,468 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.12B | 0.55% | 867,940 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.95B | -1.62% | 2,728,697 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.80B | 0.68% | 119,746 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 26.56B | 0.41% | 1,145,953 | 20.18B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.21B | -0.05% | 847,018 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.15B | 0.35% | 512,641 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.46B | -1.48% | 5,841,756 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.73B | -0.22% | 389,397 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.54B | -0.39% | 1,079,891 | 5.82B |
| 65 | MRNA | Moderna, Inc. | 24.18B | 1.27% | 6,556,328 | 2.23B |
| 66 | BNTX | BioNTech SE | 23.31B | - | 705,901 | 3.03B |
| 67 | STE | STERIS plc | 23.23B | -0.28% | 651,752 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.15B | -1.27% | 1,302,343 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.11B | -2.67% | 343,350 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 20.89B | -0.18% | 580,417 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.70B | - | 12,743,517 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.55B | -0.56% | 2,727,092 | 8.51B |
| 73 | GMAB | Genmab A/S | 18.37B | -0.06% | 1,587,051 | 4.13B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.90B | 0.51% | 159,910 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.78B | -0.41% | 418,488 | 998.25M |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.46B | -1.81% | 808,041 | 3.37B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.36B | -1.15% | 3,169,372 | 713.07M |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 16.10B | -3.33% | 1,288,296 | 4.60B |
| 79 | COO | The Cooper Companies, Inc. | 14.98B | 0.66% | 1,677,383 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.32B | -1.30% | 773,865 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.27B | -0.61% | 7,577,139 | 11.47B |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | 13.46B | 0.97% | 3,966,053 | 3.41B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.46B | 1.81% | 1,180,222 | 4.00B |
| 84 | RVTY | Revvity, Inc. | 12.91B | -0.25% | 1,287,612 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.85B | 0.09% | 240,395 | 1.50B |
| 86 | FMS | Fresenius Medical Care AG | 12.79B | -1.97% | 889,228 | 22.19B |
| 87 | ICLR | ICON Public Limited Company | 12.78B | -0.28% | 662,268 | 8.29B |
| 88 | EXEL | Exelixis, Inc. | 12.72B | -3.08% | 2,038,685 | 2.44B |
| 89 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.61B | 1.03% | 1,042,494 | 669.50M |
| 90 | SNN | Smith & Nephew plc | 12.59B | -0.23% | 859,104 | 6.30B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | 3.87% | 415,195 | 1.28B |
| 92 | EHC | Encompass Health Corporation | 12.37B | -0.37% | 1,268,727 | 6.21B |
| 93 | ALGN | Align Technology, Inc. | 12.29B | -1.75% | 550,300 | 4.14B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.09B | -2.07% | 699,821 | 830.81M |
| 95 | BTSG | BrightSpring Health Services, Inc. | 12.06B | -5.79% | 6,046,414 | 14.37B |
| 96 | SMMT | Summit Therapeutics Inc. | 12.06B | 1.65% | 4,960,367 | - |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.65B | - | 2,845,929 | 1.66B |
| 98 | GMED | Globus Medical, Inc. | 11.43B | -1.16% | 1,837,625 | 3.14B |
| 99 | DVA | DaVita Inc. | 11.37B | -2.91% | 1,105,765 | 14.01B |
| 100 | ELAN | Elanco Animal Health Incorporated | 11.36B | 2.02% | 7,552,908 | 5.02B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.30B | -2.32% | 834,305 | 776.57M |
| 102 | TECH | Bio-Techne Corporation | 11.24B | 0.04% | 3,263,790 | 1.21B |
| 103 | ABVX | ABIVAX Société Anonyme | 10.94B | -0.54% | 465,612 | 5.67M |
| 104 | GKOS | Glaukos Corporation | 10.73B | 0.32% | 723,278 | 612.84M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.63B | -1.34% | 1,270,129 | 67.67M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.52B | 2.47% | 2,371,461 | 3.50B |
| 107 | ENSG | The Ensign Group, Inc. | 10.41B | -2.03% | 235,431 | 5.49B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 10.35B | 1.01% | 320,815 | 7.46M |
| 109 | MOH | Molina Healthcare, Inc. | 10.13B | -2.16% | 345,672 | 42.47B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.11B | 0.03% | 1,060,397 | - |
| 111 | TEM | Tempus AI, Inc. | 10.05B | 1.14% | 3,778,999 | 1.43B |
| 112 | PODD | Insulet Corporation | 10.04B | 1.30% | 1,249,717 | 3.05B |
| 113 | UHS | Universal Health Services, Inc. | 9.94B | -2.33% | 611,271 | 18.11B |
| 114 | HSIC | Henry Schein, Inc. | 9.94B | 1.25% | 927,814 | 13.60B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.68B | -1.37% | 147,901 | 440.48M |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.60B | -1.14% | 306,493 | 281.99M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.53B | 0.48% | 251,918 | 2.59B |
| 118 | AVTR | Avantor, Inc. | 9.31B | 0.29% | 7,644,965 | 6.56B |
| 119 | RGEN | Repligen Corporation | 9.30B | 0.98% | 989,268 | 785.10M |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.21B | -2.67% | 2,406,943 | 874.09M |
| 121 | KYMR | Kymera Therapeutics, Inc. | 9.11B | 0.96% | 2,380,125 | 105.00M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.06B | -2.46% | 931,734 | - |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.95B | 0.25% | 1,422,025 | 42.16M |
| 124 | HQY | HealthEquity, Inc. | 8.83B | -1.14% | 553,333 | 1.34B |
| 125 | QGEN | Qiagen N.V. | 8.82B | -2.74% | 4,169,261 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.81B | 1.60% | 796,776 | - |
| 127 | BRKR | Bruker Corporation | 8.69B | 1.24% | 1,769,187 | 3.50B |
| 128 | OSCR | Oscar Health, Inc. | 8.62B | 1.08% | 5,521,984 | 15.32B |
| 129 | ATR | AptarGroup, Inc. | 8.57B | 0.80% | 343,679 | 3.93B |
| 130 | IMVT | Immunovant, Inc. | 8.45B | 2.61% | 1,138,883 | - |
| 131 | ALKS | Alkermes plc | 8.26B | -0.38% | 1,373,596 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.05B | 1.47% | 5,033,017 | 165.79M |
| 133 | LQDA | Liquidia Corporation | 7.83B | -3.27% | 1,870,875 | 288.07M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.77B | -2.28% | 728,855 | 239.92M |
| 135 | TWST | Twist Bioscience Corporation | 7.72B | -1.41% | 1,055,722 | 431.80M |
| 136 | TXG | 10x Genomics, Inc. | 7.62B | -0.15% | 4,335,236 | 616.91M |
| 137 | HNGE | Hinge Health, Inc. | 7.18B | -2.80% | 2,454,044 | 720.06M |
| 138 | HIMS | Hims & Hers Health, Inc. | 7.12B | -3.97% | 23,169,282 | 2.58B |
| 139 | PACS | PACS Group, Inc. | 7.12B | -7.22% | 784,859 | 5.55B |
| 140 | TGTX | TG Therapeutics, Inc. | 7.08B | 1.51% | 1,499,732 | 799.54M |
| 141 | CHE | Chemed Corporation | 6.99B | -2.25% | 151,807 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.99B | -0.75% | 214,932 | 8.48B |
| 143 | BLTE | Belite Bio, Inc | 6.99B | 6.17% | 237,867 | - |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.93B | -0.44% | 812,280 | - |
| 145 | CGON | CG Oncology, Inc. | 6.83B | 0.61% | 810,040 | 6.23M |
| 146 | COGT | Cogent Biosciences, Inc. | 6.72B | -6.81% | 2,781,209 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.30% | 3,933,985 | 1.56B |
| 148 | CAI | Caris Life Sciences, Inc. | 6.54B | -1.11% | 6,043,791 | 989.61M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -0.48% | 579,011 | 618.07M |
| 150 | ERAS | Erasca, Inc. | 6.36B | 1.05% | 3,426,103 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.35% | 853,740 | - |
| 152 | PTCT | PTC Therapeutics, Inc. | 6.15B | -1.25% | 763,594 | 1.01B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | -1.57% | 665,620 | 7.50M |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.07B | 1.66% | 350,850 | 840.85M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 6.07B | -2.96% | 778,223 | 1.90M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.03B | 0.24% | 195,853 | 5.32B |
| 157 | RDNT | RadNet, Inc. | 6.01B | -1.22% | 723,916 | 2.27B |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.76B | -2.35% | 368,548 | 290.54M |
| 159 | STVN | Stevanato Group S.p.A. | 5.75B | 2.28% | 446,277 | 1.40B |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.68B | -1.12% | 1,282,660 | 591.33M |
| 161 | TFX | Teleflex Incorporated | 5.66B | 0.41% | 614,258 | 2.25B |
| 162 | MMED | MiniMed Group, Inc. | 5.56B | 1.44% | 779,580 | 3.10B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.50B | -9.39% | 3,362,223 | - |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.46B | -4.36% | 2,253,313 | 3.12B |
| 165 | SHC | Sotera Health Company | 5.45B | 0.74% | 3,706,496 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.44B | 1.52% | 1,235,020 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.23B | 1.05% | 1,066,371 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.07B | 0.07% | 1,346,456 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.99B | 0.79% | 1,399,121 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | -0.61% | 1,088,170 | - |
| 171 | WAY | Waystar Holding Corp. | 4.66B | -1.62% | 2,476,282 | 1.21B |
| 172 | DOCS | Doximity, Inc. | 4.65B | 1.87% | 5,738,107 | 655.57M |
| 173 | PBLS | Parabilis Medicines, Inc. | 4.64B | 2.07% | 333,207 | - |
| 174 | BLLN | BillionToOne, Inc. | 4.62B | -0.72% | 575,335 | 397.41M |
| 175 | NVST | Envista Holdings Corporation | 4.58B | 1.17% | 2,643,430 | 2.86B |
| 176 | ICUI | ICU Medical, Inc. | 4.55B | -0.19% | 250,319 | 2.16B |
| 177 | MANE | Veradermics, Incorporated | 4.55B | -1.63% | 561,900 | - |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.54B | -0.10% | 2,196,203 | 1.33B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.44B | -4.81% | 2,259,550 | 53.81M |
| 180 | LFST | LifeStance Health Group, Inc. | 4.39B | -3.36% | 6,454,606 | 1.58B |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.38B | 0.25% | 1,976,991 | 10.35M |
| 182 | LIVN | LivaNova PLC | 4.33B | 2.81% | 673,275 | 1.47B |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.31B | -1.08% | 1,277,494 | - |
| 184 | CELC | Celcuity Inc. | 4.30B | -2.95% | 618,188 | - |
| 185 | ITGR | Integer Holdings Corporation | 4.25B | -0.03% | 1,961,257 | 1.84B |
| 186 | LEGN | Legend Biotech Corporation | 4.22B | 5.66% | 4,231,794 | 1.27B |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 4.21B | -3.14% | 796,537 | 2.29B |
| 188 | TLX | Telix Pharmaceuticals Limited | 4.07B | 1.78% | 81,750 | 803.79M |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 4.05B | -0.24% | 2,956,645 | 308.08M |
| 190 | IRTC | iRhythm Holdings, Inc. | 4.02B | -2.33% | 627,163 | 825.34M |
| 191 | HAE | Haemonetics Corporation | 3.97B | 0.70% | 745,391 | 1.35B |
| 192 | DNLI | Denali Therapeutics Inc. | 3.95B | -1.24% | 1,144,646 | 3.60M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.94B | -1.86% | 1,011,490 | - |
| 194 | VCYT | Veracyte, Inc. | 3.73B | 0.30% | 550,998 | 561.90M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.72B | -3.12% | 471,702 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.66B | 0.07% | 766,891 | 117.00M |
| 197 | OPCH | Option Care Health, Inc. | 3.61B | -1.71% | 1,942,492 | 5.69B |
| 198 | OGN | Organon & Co. | 3.58B | 0.22% | 2,687,829 | 6.13B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | 0.27% | 488,599 | 234.13M |
| 200 | CLDX | Celldex Therapeutics, Inc. | 3.48B | 3.16% | 767,362 | 158.00K |
| 201 | NHC | National HealthCare Corporation | 3.39B | -1.97% | 95,589 | 1.56B |
| 202 | GRAL | GRAIL, Inc. | 3.37B | 0.86% | 575,492 | 165.26M |
| 203 | NAMS | NewAmsterdam Pharma Company N.V. | 3.30B | -1.29% | 2,343,078 | 7.12M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | 1.20% | 1,049,956 | 463.98M |
| 205 | ALMS | Alumis Inc. | 3.23B | -7.85% | 1,324,326 | 8.40M |
| 206 | MBX | MBX Biosciences, Inc. | 3.18B | -0.21% | 359,675 | - |
| 207 | PLSE | Pulse Biosciences, Inc. | 3.17B | 6.96% | 760,058 | 1.19M |
| 208 | QURE | uniQure N.V. | 3.12B | -2.30% | 984,426 | 18.67M |
| 209 | IRON | Disc Medicine, Inc. | 3.12B | 3.74% | 254,422 | - |
| 210 | TMDX | TransMedics Group, Inc. | 3.10B | 1.07% | 876,614 | 668.47M |
| 211 | WRBY | Warby Parker Inc. | 3.10B | -5.19% | 2,218,024 | 911.61M |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 3.05B | 2.51% | 740,796 | 606.33M |
| 213 | BKD | Brookdale Senior Living Inc. | 3.00B | -8.33% | 16,710,439 | 2.93B |
| 214 | ABCL | AbCellera Biologics Inc. | 2.99B | 4.50% | 18,370,022 | 66.17M |
| 215 | IMNM | Immunome, Inc. | 2.97B | 2.18% | 886,891 | 4.02M |
| 216 | IOVA | Iovance Biotherapeutics, Inc. | 2.94B | 1.41% | 10,381,001 | 324.97M |
| 217 | ZLAB | Zai Lab Limited | 2.92B | 10.31% | 3,809,540 | 449.61M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.90B | -2.14% | 1,240,840 | 3.37B |
| 219 | PRVA | Privia Health Group, Inc. | 2.81B | -1.74% | 1,262,209 | 2.36B |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.74B | -4.21% | 4,549,138 | 4.58B |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | -0.40% | 669,683 | 830.44M |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 0.31% | 700,354 | 36.77M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.68B | -1.58% | 1,329,357 | 156.04M |
| 224 | ATAI | AtaiBeckley Inc. | 2.67B | -0.55% | 3,667,426 | 4.47M |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.65B | 0.60% | 2,138,821 | 717.00M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.64B | 5.08% | 5,034,052 | 940.61M |
| 227 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.63B | 4.23% | 833,833 | -665.00K |
| 228 | KOD | Kodiak Sciences Inc. | 2.63B | -2.97% | 515,917 | - |
| 229 | AXGN | Axogen, Inc. | 2.61B | 0.54% | 576,924 | 251.17M |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.60B | -0.39% | 3,062,936 | 71.13M |
| 231 | NKTR | Nektar Therapeutics | 2.55B | 0.85% | 325,801 | 55.63M |
| 232 | HTFL | HeartFlow, Inc. | 2.55B | 0.65% | 556,326 | 191.42M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.54B | 1.13% | 516,771 | 1.10B |
| 234 | TRVI | Trevi Therapeutics, Inc. | 2.54B | - | 1,322,180 | - |
| 235 | ALMR | Alamar Biosciences, Inc. | 2.53B | 30.65% | 1,558,298 | 100.42M |
| 236 | NEOG | Neogen Corporation | 2.51B | 0.79% | 2,286,158 | 870.40M |
| 237 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -4.85% | 705,257 | 1.46B |
| 238 | BFLY | Butterfly Network, Inc. | 2.50B | -3.40% | 5,251,363 | 112.14M |
| 239 | UFPT | UFP Technologies, Inc. | 2.49B | -0.95% | 149,356 | 631.64M |
| 240 | RGC | Regencell Bioscience Holdings Limited | 2.49B | -4.92% | 235,320 | - |
| 241 | PGEN | Precigen, Inc. | 2.46B | -2.00% | 4,876,243 | 85.72M |
| 242 | KLRA | Kailera Therapeutics, Inc. | 2.44B | -0.58% | 231,131 | - |
| 243 | CDNA | CareDx, Inc. | 2.44B | 0.34% | 638,628 | 458.09M |
| 244 | WGS | GeneDx Holdings Corp. | 2.44B | 4.96% | 647,711 | 454.43M |
| 245 | COAG | Hemab Therapeutics Holdings, Inc. | 2.42B | 3.75% | 251,553 | - |
| 246 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -0.18% | 679,796 | - |
| 247 | PHVS | Pharvaris N.V. | 2.41B | -1.21% | 477,159 | - |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 3.92% | 425,211 | 20.00M |
| 249 | BHC | Bausch Health Companies Inc. | 2.33B | -1.73% | 1,638,064 | 10.85B |
| 250 | CLOV | Clover Health Investments, Corp. | 2.33B | -3.94% | 4,330,443 | 2.48B |
| 251 | XRAY | DENTSPLY SIRONA Inc. | 2.31B | -0.43% | 4,140,782 | 3.64B |
| 252 | URGN | UroGen Pharma Ltd. | 2.30B | 1.73% | 876,551 | 188.73M |
| 253 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | 1.33% | 557,487 | 959.90M |
| 254 | VCEL | Vericel Corporation | 2.27B | 0.91% | 416,861 | 306.30M |
| 255 | NUVB | Nuvation Bio Inc. | 2.24B | -3.48% | 4,125,009 | 169.90M |
| 256 | SEPN | Septerna, Inc. | 2.23B | 22.93% | 1,159,566 | 98.88M |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 1.37% | 188,407 | - |
| 258 | ADMA | ADMA Biologics, Inc. | 2.22B | 1.59% | 2,538,515 | 512.28M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 2.21B | -1.04% | 457,150 | 245.82M |
| 260 | MESO | Mesoblast Limited | 2.21B | 1.44% | 143,663 | 65.38M |
| 261 | BHVN | Biohaven Ltd. | 2.19B | -0.34% | 2,362,955 | - |
| 262 | ATRC | AtriCure, Inc. | 2.18B | 3.15% | 562,462 | 569.62M |
| 263 | VERA | Vera Therapeutics, Inc. | 2.18B | -4.08% | 1,915,911 | - |
| 264 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | 0.09% | 4,723,060 | - |
| 265 | HCM | HUTCHMED (China) Limited | 2.15B | -0.64% | 16,917 | 549.12M |
| 266 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 5.63% | 2,175,126 | 52.06M |
| 267 | ADUS | Addus HomeCare Corporation | 2.14B | -2.05% | 216,906 | 1.48B |
| 268 | TSHA | Taysha Gene Therapies, Inc. | 2.14B | 4.87% | 4,986,364 | 7.47M |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.13B | 2.26% | 1,308,643 | 27.59M |
| 270 | NEO | NeoGenomics, Inc. | 2.12B | -0.60% | 3,723,137 | 766.30M |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.07B | 0.23% | 673,677 | 1.95B |
| 272 | NVCR | NovoCure Limited | 2.06B | 2.02% | 923,858 | 699.19M |
| 273 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 1.41% | 1,071,547 | 10.00M |
| 274 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -0.52% | 730,651 | 311.51M |
| 275 | PGNY | Progyny, Inc. | 2.04B | -4.60% | 1,298,648 | 1.31B |
| 276 | GHRS | GH Research PLC | 2.00B | -1.52% | 673,361 | - |
| 277 | KARD | Kardigan, Inc. | 1.97B | 4.65% | 293,916 | - |
| 278 | NBTX | Nanobiotix S.A. | 1.95B | 7.02% | 112,079 | 38.27M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.31% | 938,680 | 98.34M |
| 280 | AVAH | Aveanna Healthcare Holdings Inc. | 1.95B | -5.39% | 2,679,559 | 2.52B |
| 281 | SGRY | Surgery Partners, Inc. | 1.95B | -5.96% | 1,665,836 | 3.37B |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 6.05% | 3,002,648 | 1.97B |
| 283 | LMAT | LeMaitre Vascular, Inc. | 1.89B | 2.03% | 323,267 | 262.43M |
| 284 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.07% | 1,052,338 | - |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.87B | 2.78% | 234,884 | - |
| 286 | FTRE | Fortrea Holdings Inc. | 1.86B | 2.79% | 869,368 | 2.68B |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 6.76% | 492,362 | 1.13B |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.84B | -7.31% | 814,173 | 481.07M |
| 289 | GENB | Generate Biomedicines, Inc. | 1.83B | -3.06% | 443,881 | 26.48M |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -0.39% | 790,874 | 252.25M |
| 291 | CMPS | COMPASS Pathways plc | 1.81B | 1.52% | 2,190,697 | - |
| 292 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | 1.82% | 11,007,615 | 54.86M |
| 293 | TRLV | Trulieve Cannabis Corp. | 1.79B | 2.42% | 785,261 | 1.14B |
| 294 | PRGO | Perrigo Company plc | 1.78B | 1.66% | 2,271,010 | 4.14B |
| 295 | ASTH | Astrana Health, Inc. | 1.76B | -7.98% | 584,452 | 3.84B |
| 296 | IMCR | Immunocore Holdings plc | 1.76B | 0.59% | 283,530 | 430.78M |
| 297 | ZYME | Zymeworks Inc. | 1.73B | 0.66% | 461,234 | 37.13M |
| 298 | ANAB | AnaptysBio, Inc. | 1.71B | 4.33% | 372,049 | 232.39M |
| 299 | INSP | Inspire Medical Systems, Inc. | 1.71B | -0.99% | 385,365 | 898.74M |
| 300 | AAPG | Ascentage Pharma Group International | 1.71B | 0.64% | 3,279 | 82.08M |
| 301 | BLFS | BioLife Solutions, Inc. | 1.70B | 0.52% | 410,586 | 106.69M |
| 302 | NTLA | Intellia Therapeutics, Inc. | 1.68B | - | 2,569,330 | 59.51M |
| 303 | OMCL | Omnicell, Inc. | 1.68B | -1.21% | 464,847 | 1.25B |
| 304 | XNCR | Xencor, Inc. | 1.64B | 2.41% | 1,109,971 | 104.97M |
| 305 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -1.69% | 225,984 | 95.13M |
| 306 | TRAX | First Tracks Biotherapeutics, Inc. | 1.63B | -2.44% | 613,566 | - |
| 307 | TNDM | Tandem Diabetes Care, Inc. | 1.63B | 2.76% | 1,784,825 | 1.04B |
| 308 | BRVE | Braveheart Bio, Inc. | 1.60B | -9.15% | 724,629 | - |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -1.53% | 526,171 | 978.38M |
| 310 | ABSI | Absci Corporation | 1.59B | 4.44% | 2,880,841 | 1.56M |
| 311 | AVLN | Avalyn Pharma Inc. | 1.57B | 2.60% | 219,803 | - |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.56B | -14.32% | 1,715,178 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.55B | -0.81% | 323,308 | 6.41B |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.53B | 5.01% | 1,779,001 | 335.41M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.51B | 0.11% | 379,878 | 20.00M |
| 316 | VIR | Vir Biotechnology, Inc. | 1.51B | 0.45% | 1,203,045 | 303.23M |
| 317 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.51B | -4.28% | 2,424,075 | 208.78M |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.50B | -4.08% | 729,966 | - |
| 319 | INVA | Innoviva, Inc. | 1.50B | 0.34% | 595,957 | 440.00M |
| 320 | PSNL | Personalis, Inc. | 1.50B | -3.31% | 3,232,967 | 69.67M |
| 321 | CNMD | CONMED Corporation | 1.48B | 0.24% | 239,804 | 1.37B |
| 322 | HROW | Harrow, Inc. | 1.48B | -3.14% | 1,912,684 | 275.59M |
| 323 | OMDA | Omada Health, Inc. | 1.47B | -3.92% | 1,906,411 | 309.76M |
| 324 | AZTA | Azenta, Inc. | 1.46B | 0.18% | 608,835 | 613.81M |
| 325 | LBRX | LB Pharmaceuticals Inc | 1.46B | -1.13% | 235,735 | - |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 1.29% | 453,364 | - |
| 327 | AGL | agilon health, inc. | 1.45B | -10.74% | 394,003 | 5.92B |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.45B | -1.26% | 1,463,389 | 815.05M |
| 329 | HCSG | Healthcare Services Group, Inc. | 1.44B | -3.81% | 719,773 | 1.86B |
| 330 | OBX | Obsidian Therapeutics, Inc. | 1.43B | -6.00% | 89,939 | - |
| 331 | ORIC | ORIC Pharmaceuticals, Inc. | 1.42B | 0.81% | 1,020,177 | - |
| 332 | JBIO | Jade Biosciences, Inc. | 1.42B | 2.85% | 525,626 | - |
| 333 | ENOV | Enovis Corporation | 1.42B | 1.49% | 887,604 | 2.30B |
| 334 | SVRA | Savara Inc. | 1.41B | -2.79% | 1,263,916 | - |
| 335 | MLTX | MoonLake Immunotherapeutics | 1.41B | -4.27% | 3,606,366 | - |
| 336 | VOR | Vor Biopharma Inc. | 1.40B | 0.94% | 646,542 | - |
| 337 | SDGR | Schrödinger, Inc. | 1.40B | -0.64% | 1,434,840 | 259.04M |
| 338 | INNV | InnovAge Holding Corp. | 1.39B | -6.15% | 205,861 | 949.17M |
| 339 | AORT | Artivion, Inc. | 1.38B | 7.91% | 884,606 | 471.47M |
| 340 | PAHC | Phibro Animal Health Corporation | 1.38B | -0.20% | 105,395 | 1.50B |
| 341 | AKTS | Aktis Oncology, Inc. | 1.37B | 2.78% | 209,219 | 8.28M |
| 342 | ALVO | Alvotech | 1.36B | 0.80% | 772,808 | 562.04M |
| 343 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -0.78% | 260,022 | 1.30M |
| 344 | FRNM | Freenome, Inc. | 1.35B | 3.27% | 1,060,602 | 34.24M |
| 345 | IART | Integra LifeSciences Holdings Corporation | 1.35B | 1.76% | 609,917 | 1.65B |
| 346 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | -0.38% | 704,391 | 28.73M |
| 347 | PNTG | The Pennant Group, Inc. | 1.33B | -3.71% | 226,604 | 1.10B |
| 348 | IMTX | Immatics N.V. | 1.33B | 0.31% | 264,408 | 43.00M |
| 349 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 4.93% | 882,981 | - |
| 350 | NVAX | Novavax, Inc. | 1.31B | 0.76% | 2,607,367 | 413.80M |
| 351 | PRCT | PROCEPT BioRobotics Corporation | 1.31B | 5.44% | 1,398,224 | 337.34M |
| 352 | GDRX | GoodRx Holdings, Inc. | 1.30B | 3.83% | 1,917,648 | 785.23M |
| 353 | AMN | AMN Healthcare Services, Inc. | 1.28B | -9.54% | 1,223,114 | 3.43B |
| 354 | REPL | Replimune Group, Inc. | 1.28B | -0.15% | 4,766,946 | - |
| 355 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | 7.39% | 808,167 | - |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 1.48% | 103,463 | - |
| 357 | STAA | STAAR Surgical Company | 1.24B | -0.72% | 827,057 | 290.38M |
| 358 | CERT | Certara, Inc. | 1.24B | 0.74% | 2,355,798 | 421.75M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 7.21% | 834,528 | - |
| 360 | TDOC | Teladoc Health, Inc. | 1.24B | -3.81% | 3,393,303 | 2.49B |
| 361 | MNKD | MannKind Corporation | 1.23B | -2.29% | 4,497,586 | 393.63M |
| 362 | USPH | U.S. Physical Therapy, Inc. | 1.22B | -0.09% | 179,762 | 804.27M |
| 363 | MGTX | MeiraGTx Holdings plc | 1.21B | 0.23% | 288,613 | 79.76M |
| 364 | AHG | Akso Health Group | 1.19B | 2.96% | 10,002 | 13.83M |
| 365 | LTGO | Latigo Biotherapeutics, Inc. | 1.17B | -0.22% | 237,861 | - |
| 366 | BVS | Bioventus Inc. | 1.16B | -0.79% | 538,113 | 581.85M |
| 367 | ETON | Eton Pharmaceuticals, Inc. | 1.15B | -3.71% | 584,578 | 86.93M |
| 368 | NUTX | Nutex Health Inc. | 1.14B | -15.73% | 255,789 | 846.72M |
| 369 | IRMD | IRADIMED CORPORATION | 1.14B | -1.47% | 184,275 | 86.34M |
| 370 | CRON | Cronos Group Inc. | 1.14B | 2.67% | 1,205,492 | 179.09M |
| 371 | SANA | Sana Biotechnology, Inc. | 1.13B | 4.99% | 2,520,205 | - |
| 372 | EYPT | EyePoint, Inc. | 1.13B | -0.15% | 2,058,472 | 2.79M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.68% | 807,063 | 1.03B |
| 374 | ANRO | Alto Neuroscience, Inc. | 1.12B | 1.73% | 228,522 | - |
| 375 | IVA | Inventiva S.A. | 1.12B | -0.63% | 382,924 | 7.94M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.25% | 3,031,982 | 41.47M |
| 377 | GERN | Geron Corporation | 1.05B | 10.14% | 12,716,753 | 204.56M |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -1.52% | 714,964 | 59.00K |
| 379 | OPK | OPKO Health, Inc. | 1.04B | - | 1,840,695 | 587.90M |
| 380 | JANX | Janux Therapeutics, Inc. | 1.01B | 0.67% | 577,857 | 24.00M |
| 381 | WVE | Wave Life Sciences Ltd. | 994.11M | -16.89% | 6,918,054 | 65.37M |
| 382 | APMD | Apnimed, Inc. | 990.40M | -10.99% | 174,675 | 120.15M |
| 383 | CSTL | Castle Biosciences, Inc. | 984.92M | -0.34% | 313,472 | 357.28M |
| 384 | OMER | Omeros Corporation | 984.30M | -0.15% | 1,887,941 | 9.89M |
| 385 | ARDX | Ardelyx, Inc. | 981.80M | -1.50% | 8,166,363 | 450.89M |
| 386 | ODTX | Odyssey Therapeutics, Inc. | 975.14M | -8.21% | 107,743 | 99.00K |
| 387 | PCRX | Pacira BioSciences, Inc. | 971.83M | -0.20% | 802,591 | 746.16M |
| 388 | QDEL | QuidelOrtho Corporation | 959.37M | 1.75% | 1,495,549 | 2.67B |
| 389 | SLDB | Solid Biosciences Inc. | 948.94M | 3.39% | 900,422 | - |
| 390 | GMRS | GMR Solutions Inc. | 924.77M | -5.93% | 269,323 | 5.83B |
| 391 | ABUS | Arbutus Biopharma Corporation | 922.50M | 1.74% | 1,047,749 | 191.45M |
| 392 | DSGN | Design Therapeutics, Inc. | 914.94M | 2.02% | 313,443 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -12.65% | 2,671,324 | - |
| 394 | GLAS | Glass House Brands Inc. | 895.03M | -0.30% | 234,008 | 177.68M |
| 395 | AVR | Anteris Technologies Global Corp. | 893.67M | 2.34% | 1,105,049 | 2.24M |
| 396 | KURA | Kura Oncology, Inc. | 881.53M | 0.81% | 876,701 | 71.64M |
| 397 | TBPH | Theravance Biopharma, Inc. | 878.47M | 0.06% | 952,370 | 104.31M |
| 398 | ANNX | Annexon, Inc. | 874.92M | -0.93% | 924,789 | - |
| 399 | ACRS | Aclaris Therapeutics, Inc. | 871.42M | 0.34% | 1,210,167 | 8.22M |
| 400 | INMD | InMode Ltd. | 870.26M | -0.33% | 355,395 | 374.63M |
| 401 | TALK | Talkspace, Inc. | 868.92M | - | 1,769,977 | 245.73M |
| 402 | AMPH | Amphastar Pharmaceuticals, Inc. | 868.62M | 0.54% | 570,491 | 730.02M |
| 403 | COLL | Collegium Pharmaceutical, Inc. | 845.79M | -4.49% | 1,287,859 | 808.21M |
| 404 | SIBN | SI-BONE, Inc. | 842.59M | -0.21% | 415,983 | 213.60M |
| 405 | DBVT | DBV Technologies S.A. | 834.54M | -1.26% | 376,363 | 5.04M |
| 406 | AURA | Aura Biosciences, Inc. | 833.79M | 4.42% | 1,008,525 | - |
| 407 | SGP | SpyGlass Pharma, Inc. | 831.18M | -1.23% | 64,990 | - |
| 408 | HSTM | HealthStream, Inc. | 829.25M | -3.44% | 201,688 | 321.12M |
| 409 | IMMX | Immix Biopharma, Inc. | 821.99M | 13.43% | 1,820,869 | - |
| 410 | CBLL | CeriBell, Inc. | 814.54M | 10.41% | 1,859,763 | 101.96M |
| 411 | ATTO | Attovia Therapeutics, Inc. | 802.49M | -6.00% | 475,600 | 1.35M |
| 412 | PHAR | Pharming Group N.V. | 799.42M | 7.75% | 89,771 | 366.48M |
| 413 | CLYM | Climb Bio, Inc. | 795.49M | 2.29% | 707,175 | - |
| 414 | BBNX | Beta Bionics, Inc. | 792.72M | 7.44% | 613,893 | 119.01M |
| 415 | DRUG | Bright Minds Biosciences Inc. | 792.01M | -0.67% | 350,378 | - |
| 416 | OCS | Oculis Holding AG | 787.08M | -0.08% | 143,100 | 1.45M |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 784.93M | 0.86% | 208,245 | 276.79M |
| 418 | VREX | Varex Imaging Corporation | 783.11M | 0.65% | 3,515,776 | 865.00M |
| 419 | CADL | Candel Therapeutics, Inc. | 780.33M | 1.43% | 857,151 | - |
| 420 | FTH | Faeth Therapeutics, Inc. | 775.21M | 5.01% | 217,387 | - |
| 421 | MNPR | Monopar Therapeutics Inc. | 766.74M | -1.62% | 210,761 | - |
| 422 | EVO | Evotec SE | 760.14M | 0.96% | 50,427 | 859.03M |
| 423 | PHR | Phreesia, Inc. | 758.43M | -1.37% | 747,754 | 495.59M |
| 424 | AHCO | AdaptHealth Corp. | 753.76M | 8.24% | 5,296,430 | 3.36B |
| 425 | CTMX | CytomX Therapeutics, Inc. | 751.75M | 0.29% | 1,698,607 | 18.30M |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 736.99M | -0.86% | 202,029 | - |
| 427 | ALLO | Allogene Therapeutics, Inc. | 731.73M | 0.95% | 4,967,298 | 22.00K |
| 428 | AGMB | AgomAb Therapeutics NV | 731.33M | -1.00% | 60,988 | - |
| 429 | SSII | SS Innovations International, Inc. | 722.47M | -3.73% | 8,972 | 48.47M |
| 430 | CBIO | Crescent Biopharma, Inc. | 714.35M | -3.69% | 96,598 | 11.88M |
| 431 | NGNE | Neurogene Inc. | 713.38M | -2.05% | 352,596 | 925.00K |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 710.53M | 6.17% | 1,929,785 | 389.32M |
| 433 | GYRE | Gyre Therapeutics, Inc. | 704.06M | -1.19% | 50,197 | 109.82M |
| 434 | RGNX | REGENXBIO Inc. | 703.04M | 2.21% | 881,082 | 174.48M |
| 435 | SLN | Silence Therapeutics plc | 695.28M | -4.60% | 3,289,319 | 615.00K |
| 436 | ACHV | Achieve Life Sciences, Inc. | 695.00M | 1.50% | 1,997,590 | - |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 675.95M | -0.70% | 1,787,203 | 239.66M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 673.41M | -1.22% | 710,553 | 136.07M |
| 439 | ANGO | AngioDynamics, Inc. | 650.99M | - | 839,061 | 320.17M |
| 440 | TLRY | Tilray Brands, Inc. | 648.24M | 8.14% | 5,685,481 | 915.45M |
| 441 | SOPH | SOPHiA GENETICS SA | 647.82M | -0.78% | 355,610 | 86.17M |
| 442 | VSTM | Verastem, Inc. | 638.47M | 3.83% | 2,087,629 | 87.53M |
| 443 | KIDS | OrthoPediatrics Corp. | 632.90M | 4.12% | 231,372 | 252.72M |
| 444 | NVCT | Nuvectis Pharma, Inc. | 632.41M | 2.81% | 166,241 | - |
| 445 | STLN | Starling Oncology, Inc. | 631.37M | 0.57% | 1,792,458 | 587.24M |
| 446 | MDXG | MiMedx Group, Inc. | 629.69M | 1.17% | 1,228,724 | 355.17M |
| 447 | HELP | Cybin Inc. | 625.42M | 0.80% | 988,010 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 623.04M | -2.57% | 162,585 | - |
| 449 | AUTL | Autolus Therapeutics plc | 620.11M | 12.56% | 7,686,267 | 117.39M |
| 450 | CTKB | Cytek Biosciences, Inc. | 616.12M | 1.72% | 1,172,089 | 206.71M |
| 451 | BWAY | BrainsWay Ltd. | 605.95M | -2.22% | 119,283 | 56.22M |
| 452 | FDMT | 4D Molecular Therapeutics, Inc. | 599.61M | 2.96% | 453,647 | 88.24M |
| 453 | DCTH | Delcath Systems, Inc. | 597.51M | 3.30% | 1,228,262 | 95.42M |
| 454 | CTEV | Claritev Corporation | 592.48M | 2.61% | 140,569 | 994.67M |
| 455 | SGMT | Sagimet Biosciences Inc. | 591.75M | -0.52% | 1,480,412 | - |
| 456 | SPRY | ARS Pharmaceuticals, Inc. | 590.85M | 0.68% | 1,351,809 | 98.99M |
| 457 | ARVN | Arvinas, Inc. | 587.82M | - | 572,103 | 316.70M |
| 458 | ALT | Altimmune, Inc. | 583.42M | -1.64% | 3,634,624 | 36.00K |
| 459 | PRME | Prime Medicine, Inc. | 579.97M | 3.49% | 2,258,047 | 4.07M |
| 460 | ARTV | Artiva Biotherapeutics, Inc. | 575.93M | 4.99% | 456,609 | 251.00K |
| 461 | CRMD | CorMedix Inc. | 572.70M | -3.05% | 1,182,274 | 400.05M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 557.55M | 2.28% | 903,223 | - |
| 463 | EIKN | Eikon Therapeutics, Inc. | 553.84M | 5.14% | 502,388 | - |
| 464 | AQST | Aquestive Therapeutics, Inc. | 553.31M | 2.80% | 6,494,934 | 54.09M |
| 465 | EOLS | Evolus, Inc. | 550.86M | 10.17% | 2,794,648 | 316.49M |
| 466 | STTK | Shattuck Labs, Inc. | 550.57M | 0.56% | 1,906,285 | 1.00M |
| 467 | PRLD | Prelude Therapeutics Incorporated | 547.93M | 10.14% | 698,440 | 22.42M |
| 468 | TCMD | Tactile Systems Technology, Inc. | 544.73M | -17.12% | 1,438,573 | 350.31M |
| 469 | MPLT | MapLight Therapeutics, Inc. | 543.24M | -1.64% | 359,010 | - |
| 470 | VALN | Valneva SE | 542.72M | 5.47% | 99,032 | 180.25M |
| 471 | SRTA | Strata Critical Medical, Inc. | 533.45M | 1.52% | 1,114,929 | 255.98M |
| 472 | ZURA | Zura Bio Limited | 532.81M | -1.24% | 1,598,647 | - |
| 473 | ASMB | Assembly Biosciences, Inc. | 524.97M | 1.98% | 213,244 | 71.10M |
| 474 | ANL | Adlai Nortye Ltd. | 523.20M | -1.13% | 134,800 | 5.00M |
| 475 | FLGT | Fulgent Genetics, Inc. | 522.79M | -0.31% | 155,879 | 323.93M |
| 476 | ENTX | Entera Bio Ltd. | 519.43M | -1.32% | 487,911 | 42.00K |
| 477 | CERS | Cerus Corporation | 516.91M | 1.79% | 3,526,707 | 221.55M |
| 478 | EVMN | Evommune, Inc. | 515.71M | 1.00% | 380,239 | 10.00M |
| 479 | NPCE | NeuroPace, Inc. | 513.11M | 1.14% | 247,705 | 106.99M |
| 480 | BLSM | BlossomHill Therapeutics, Inc. | 506.23M | 3.31% | 328,257 | - |
| 481 | DNA | Ginkgo Bioworks Holdings, Inc. | 505.73M | -1.83% | 1,348,458 | 132.42M |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 483 | OABI | OmniAb, Inc. | 491.42M | -0.29% | 1,191,340 | 38.46M |
| 484 | BIOA | BioAge Labs, Inc. | 489.72M | -6.81% | 760,740 | 10.36M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 487.58M | 1.65% | 657,564 | - |
| 486 | PROK | ProKidney Corp. | 486.74M | -4.73% | 2,799,545 | 818.00K |
| 487 | RZLT | Rezolute, Inc. | 482.64M | -1.28% | 641,976 | - |
| 488 | OVID | Ovid Therapeutics Inc. | 481.53M | -1.53% | 903,158 | 7.12M |
| 489 | IKT | Inhibikase Therapeutics, Inc. | 478.78M | -0.41% | 580,740 | 1.00 |
| 490 | RLMD | Relmada Therapeutics, Inc. | 476.81M | -1.54% | 2,140,735 | - |
| 491 | PRTA | Prothena Corporation plc | 473.33M | 1.10% | 475,251 | 54.53M |
| 492 | NRC | NRC Health | 472.92M | 2.30% | 121,289 | 140.00M |
| 493 | OCGN | Ocugen, Inc. | 464.58M | 4.58% | 2,471,407 | 4.58M |
| 494 | EVH | Evolent Health, Inc. | 463.54M | 4.33% | 4,838,384 | 2.10B |
| 495 | BNTC | Benitec Biopharma Inc. | 463.10M | -2.18% | 53,606 | - |
| 496 | QTTB | Q32 Bio Inc. | 458.75M | -1.66% | 614,784 | 53.74M |
| 497 | CABA | Cabaletta Bio, Inc. | 454.92M | -0.36% | 3,526,529 | - |
| 498 | CLPT | ClearPoint Neuro, Inc. | 454.51M | 2.26% | 712,217 | 42.28M |
| 499 | NNNN | Anbio Biotechnology | 454.27M | 1.57% | 24,668 | 8.65M |
| 500 | EDIT | Editas Medicine, Inc. | 453.06M | 4.98% | 1,910,927 | 47.01M |